Welcome to our dedicated page for Sally Beauty Hldgs SEC filings (Ticker: SBH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sally Beauty Holdings, Inc. (NYSE: SBH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a New York Stock Exchange–listed issuer with common stock registered under Section 12(b) of the Exchange Act, Sally Beauty Holdings submits periodic and current reports, proxy materials, and other documents that give investors detailed information about its operations in the cosmetics, beauty supplies, and perfume stores industry.
Among the key filings available are annual and quarterly reports, which discuss the performance of the company’s two primary businesses, Sally Beauty Supply and Beauty Systems Group. These reports typically include information on consolidated net sales, comparable sales, segment results, gross margin, operating earnings, cash flow from operations, and the use of non-GAAP financial measures such as Adjusted Operating Earnings, Adjusted EBITDA, and Free Cash Flow, along with reconciliations to the most directly comparable GAAP metrics.
Investors can also review current reports on Form 8-K, which Sally Beauty Holdings uses to furnish earnings releases and updates on strategy and business outlook, as well as to disclose items such as amendments to its by-laws. For example, the company has filed 8-Ks to report quarterly and annual financial results and to describe changes to its Amended and Restated By-Laws adopted by the board of directors.
The company’s definitive proxy statement on Schedule 14A is another important filing, outlining board composition, director elections, executive compensation practices, advisory votes on pay, auditor ratification, and governance topics such as board diversity, sustainability, human capital, culture and belonging, and risk oversight. Stock Titan’s SEC filings page surfaces these documents and pairs them with AI-powered summaries to help readers understand the main points of lengthy filings, identify items such as compensation policies or by-law changes, and quickly locate information relevant to their analysis of SBH.
Sally Beauty Holdings reported modest sales growth but lower profit for the quarter ended December 31, 2025. Net sales rose 0.6% to
Gross profit increased to
Cash flow strengthened, with cash provided by operating activities rising to
Sally Beauty Holdings reported first quarter fiscal 2026 net sales of $943.2 million, up 0.6% from a year earlier, with consolidated gross margin improving to 51.2%. GAAP net earnings were $45.6 million, down 25.3%, and diluted EPS was $0.45, down 22.4%.
On a non-GAAP basis, adjusted net earnings were $48.5 million and adjusted diluted EPS was $0.48. Adjusted EBITDA was $111.0 million, representing an 11.8% margin. Free cash flow reached $57.5 million, supported by $93.2 million of operating cash flow.
The company ended December 31, 2025 with $157 million in cash, inventory of $978.8 million, total assets of $2.85 billion and a net debt leverage ratio of 1.5x. Management reaffirmed most fiscal 2026 guidance and nudged full-year adjusted diluted EPS to $2.02–$2.10.
Sally Beauty Holdings director Max R. Rangel received a new equity award in the form of restricted stock units. On 1/22/2026, he was granted 9,975 RSUs at a stated price of $0 per unit, meaning there was no cash paid for the award. Each RSU represents the right to receive one share of SBH common stock.
All 9,975 RSUs will vest on the earlier of 1/22/2027 or the date of Sally Beauty Holdings’ next annual meeting of stockholders, so the award is subject to continued service through that time. Following this grant, Rangel beneficially holds 9,975 derivative securities directly in the form of these RSUs, with settlement in common stock upon vesting.
Sally Beauty Holdings director Debra Golding Perelman received a new equity grant in the form of restricted stock units. On 01/22/2026, she was awarded 9,975 restricted stock units at a price of $0 per unit, reported as a derivative security. These units convert into Sally Beauty common stock on a one-for-one basis.
All 9,975 restricted stock units will vest in full on the earlier of January 22, 2027 or the date of the company’s next annual meeting of stockholders. Following this grant, Perelman beneficially owns 9,975 derivative securities directly in the form of these restricted stock units, reflecting routine director equity compensation.
Sally Beauty Holdings director Erin Nealy Cox received a new equity award in the form of restricted stock units (RSUs). On January 22, 2026, she was granted 9,975 RSUs at a price of $0 per unit, reported as a derivative security.
The RSUs convert into Sally Beauty common stock on a one-for-one basis, meaning each unit represents one share when settled. According to the disclosure, 100% of the RSUs vest when her service as a director ends. After this grant, she beneficially owns 9,975 derivative securities directly.
James M. Head, a director of Sally Beauty Holdings, Inc. (SBH), received 9,975 restricted stock units (RSUs) on
Sally Beauty Holdings director Rachel Rothe Bishop reported equity-based compensation and a related share conversion. On 01/22/2026, she received 9,975 restricted stock units (RSUs), which each convert into one share of SBH common stock. All of these RSUs are scheduled to vest on the earlier of 01/22/2027 or the company’s next annual meeting of stockholders. The same day, 14,532 RSUs were converted into 14,532 shares of common stock at a stated price of $0 per share, increasing her directly held common stock to 36,231 shares.
Sally Beauty Holdings director Jeffrey N. Boyer reported equity transactions dated 01/22/2026. He acquired 9,975 restricted stock units (RSUs) at an exercise price of
On the same date, Boyer also exercised 14,532 RSUs at
Sally Beauty Holdings director Dorlisa K. Flur reported equity-based compensation activity involving company stock. On 01/22/2026, 14,532 Restricted Stock Units were exercised at $0 into 14,532 shares of common stock, increasing her directly held common shares to 57,138 after the transaction. The same day, she received a new grant of 9,975 Restricted Stock Units at $0, each convertible into one share of Sally Beauty common stock.
All 9,975 new RSUs are scheduled to vest on the earlier of 01/22/2027 or the date of Sally Beauty’s next Annual Meeting of Stockholders. These transactions reflect routine director compensation and equity vesting rather than open-market buying or selling.
Sally Beauty Holdings director Molloy Lawrence reported equity compensation activity involving restricted stock units (RSUs) and common stock. On January 22, 2026, Lawrence acquired 9,975 RSUs at an exercise price of $0. These RSUs convert into Sally Beauty Holdings common stock on a one-for-one basis and are scheduled to vest in full when Lawrence’s service as a director ends.
On the same date, Lawrence exercised RSUs covering 14,532 shares, converting them into an equal number of common shares at a price of $0. Following this settlement, Lawrence directly owned 30,002 shares of common stock, reflecting updated direct beneficial ownership after the reported transactions.
FAQ
What is the current stock price of Sally Beauty Hldgs (SBH)?
What is the market cap of Sally Beauty Hldgs (SBH)?
